SEC Form 4 · accession 0000899243-16-011353
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ted W Love
Officer — See Remarks · Director
Period of report
Aug 17, 2015
Accepted (ET)
Jan 7, 2016 · 9:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | P | 5,000 | $20.00 | A | 1,140,711 | D | |
| Common StockF1 | Aug 17, 2015 | P | 2,500 | $20.00 | A | 2,500 | I | By daughter |
| Common StockF1 | Aug 17, 2015 | P | 2,500 | $20.00 | A | 2,500 | I | By daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Remarks
Chief Executive Officer and President